Literature DB >> 2553553

Prostaglandin E2 and leukotriene B4 synthesis by peripheral leucocytes in alcoholics.

W J Maxwell1, J J Keating, F P Hogan, N P Kennedy, P W Keeling.   

Abstract

Alcohol inhibits phospholipase (PL) activity in a number of animal models. We have therefore measured prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), liberated by stimulated peripheral blood mononuclear cells (PBMC) and neutrophils respectively in chronic alcoholics and in control subjects. Peripheral blood mononuclear cells from alcoholics produced less PGE2 (p less than 0.01) and neutrophils produced less LTB4 (p less than 0.025). Reduced PGE2 production by PBMC of alcoholics was corrected by the addition of exogenous arachidonic acid (p less than 0.005) whilst neutrophil LTB4 production remained lower in the alcoholics (p less than 0.01). Percutaneous liver biopsies were undertaken in the 20 alcoholics having abnormal liver function tests. Prostaglandin E2 biosynthesis was lower in PBMC from patients with alcoholic hepatitis than with alcoholic cirrhosis (p less than 0.05). Analysis of PBMC fatty acid composition demonstrated that endogenous arachidonate and linoleate contents were not significantly different in alcoholics and controls. Cells from controls and alcoholics were incubated with 0, 50 and 150 mmol/l ethanol for two hours but there was no alteration in PGE2 or LTB4 biosynthesis. In summary, we found reduced eicosanoid production by peripheral leucocytes in alcoholics, supporting the hypothesis that chronic alcohol consumption either inhibits membrane bound phospholipase activity or enhances, alternatively, catabolism of eicosanoids. This phenomenon is more marked in alcoholic patients with hepatitis than in those with cirrhosis alone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553553      PMCID: PMC1434254          DOI: 10.1136/gut.30.9.1270

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

Review 1.  Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse.

Authors:  W K Lelbach
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

Review 2.  The calcium messenger system (2).

Authors:  H Rasmussen
Journal:  N Engl J Med       Date:  1986-05-01       Impact factor: 91.245

3.  Inhibition by ethanol and mepacrine of phospholipase-dependent prostaglandin release from the isolated perfused rat lung.

Authors:  S H Peers; J R Hoult
Journal:  Eur J Pharmacol       Date:  1986-01-21       Impact factor: 4.432

4.  Genetic and environmental factors in the individual susceptibility to the development of alcoholic liver disease.

Authors:  R D Johnson; R Williams
Journal:  Alcohol Alcohol       Date:  1985       Impact factor: 2.826

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

Review 6.  The relation of leukotrienes to liver injury.

Authors:  D Keppler; W Hagmann; S Rapp; C Denzlinger; H K Koch
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

Review 7.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

8.  Phospholipase activity and plasma membrane homeostasis.

Authors:  J A Scott
Journal:  J Theor Biol       Date:  1984-12-21       Impact factor: 2.691

Review 9.  Eicosanoids, signal molecules of liver cells.

Authors:  K Decker
Journal:  Semin Liver Dis       Date:  1985-05       Impact factor: 6.115

10.  Cytoprotective effect of prostaglandins on isolated rat liver cells.

Authors:  F Guarner; M Fremont-Smith; J Prieto
Journal:  Liver       Date:  1985-02
View more
  2 in total

1.  Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.

Authors:  Konstantina Sargenti; Åsa Johansson; Sara Bertilsson; Inger Mattsby-Baltzer; Daniel Klintman; Evangelos Kalaitzakis
Journal:  Dig Dis Sci       Date:  2016-03-24       Impact factor: 3.199

2.  Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease.

Authors:  Leila Gobejishvili; Smita Ghare; Rehan Khan; Alexander Cambon; David F Barker; Shirish Barve; Craig McClain; Daniell Hill
Journal:  Clin Immunol       Date:  2015-09-25       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.